Literature DB >> 6548856

The immediate IOP response of Nd-YAG-laser iridotomy and its prophylactic treatability.

W Schrems, O Eichelbrönner, G K Krieglstein.   

Abstract

The response of IOP in the normotensive human eye to Neodym-YAG-laser iridotomy was investigated in this study. In 2 series of 10 patients, each unilateral laser iridotomy was performed with a YAG-laser prior to cataract surgery. In one group laser iridotomy was done without pre-treatment, in the second group laser iridotomy was preceded by treatment with 1% pilocarpine. Close follow-up of IOP before and after surgery was carried out with the Non-Contact-Tonometer. Laser iridotomy caused average IOP rises of 10 mmHg, which could be identified as early as 20 min after surgery, with a maximum of response after 80 min, and a declining IOP from 100 min post-operatively onwards. Pre-treatment with pilocarpine eyedrops could be reduce the laser-mediated IOP rise to less than one fourth. These results recommend a mild miotic for routine pre-treatment for iris laser surgery in order to cope with acute pressure rise as one of the major problems in these procedures.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6548856     DOI: 10.1111/j.1755-3768.1984.tb05794.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  9 in total

1.  The role of apraclonidine hydrochloride in laser therapy for glaucoma.

Authors:  A L Robin
Journal:  Trans Am Ophthalmol Soc       Date:  1989

2.  The prevention of an acute rise in intraocular pressure following Q-switched Nd:YAG laser iridotomy with clonidine.

Authors:  Y Kitazawa; K Sugiyama; T Taniguchi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

3.  Study of the first hundred phakic eyes treated by peripheral iridotomy using the N.D. Yag laser.

Authors:  J Haut; I Gaven; F Moulin; P Larricart; J M Marre; G Van Effenterre
Journal:  Int Ophthalmol       Date:  1986-12       Impact factor: 2.031

4.  Prevention of IOP-rise following Nd-YAG laser capsulotomy with pre-operative timolol eye-drops and 1 tablet acetazolamide 250 mg systematically.

Authors:  T N Boen-Tan; J S Stilma
Journal:  Doc Ophthalmol       Date:  1986-12-30       Impact factor: 2.379

5.  Prevention of IOP-rise following Nd-YAG laser capsulotomy with topical timolol and indomethacin.

Authors:  D Van der Feltz van der Sloot; J S Stilma; T N Boen-Tan; P D Bezemer
Journal:  Doc Ophthalmol       Date:  1988 Oct-Nov       Impact factor: 2.379

6.  Immediate changes in intraocular pressure after laser peripheral iridotomy in primary angle-closure suspects.

Authors:  Yuzhen Jiang; Dolly S Chang; Paul J Foster; Mingguang He; Shengsong Huang; Tin Aung; David S Friedman
Journal:  Ophthalmology       Date:  2011-10-29       Impact factor: 12.079

Review 7.  New developments in the drug treatment of glaucoma.

Authors:  L M Hurvitz; P L Kaufman; A L Robin; R N Weinreb; K Crawford; B Shaw
Journal:  Drugs       Date:  1991-04       Impact factor: 9.546

8.  Efficacy and safety of apraclonidine in patients undergoing anterior segment laser surgery.

Authors:  B Sridharrao; S S Badrinath
Journal:  Br J Ophthalmol       Date:  1989-11       Impact factor: 4.638

9.  Neodymium-YAG laser iridotomy.

Authors:  D J Brazier
Journal:  J R Soc Med       Date:  1986-11       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.